Sean Collens

Sean Collens is a seasoned biologist with extensive experience in the development of novel cancer radiotherapies. Currently serving as a Senior Research Associate II at Fusion Pharmaceuticals since May 2017, Sean previously held the position of Senior Research Associate I at the same company. Prior to that, Sean contributed to the in vitro and in vivo evaluation of novel radiopharmaceutical agents as a Research Associate II at the Centre for Probe Development and Commercialization from January 2011 to May 2017. Earlier roles include Research Associate at Hoffmann-La Roche Ltd from 2009 to 2010 and Research Technician at Vasogen from 2003 to 2008.